Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Waleed Kamel Da'Na
Observed names:
Da'na, Waleed,
Da’na W,
Waleed Da'Na,
Waleed Da'na,
Waleed Dana,
Waleed Da’na
show all 6
Institution:
King Hussein Cancer Center
Observed institutions:
University Health Network,
The University of Texas MD Anderson Cancer Center,
University of Toronto,
King Hussein Cancer Center,
Princess Margaret Cancer Centre,
Centre Hospitalier Universitaire de Montpellier
show all 6
OpenAlex ID:
A5113348694
Physical therapy pathway and protocol for patients undergoing hematopoietic stem cell transplantation
2019
·
Jaleel Mohammed
, Mahmoud Aljurf
, et al.
·
Hematology/Oncology and Stem Cell Therapy
·
29
Therapy of posttransplant poor graft function with eltrombopag
2020
·
Khalid Halahleh
, Robert Peter Gale
, et al.
·
Bone Marrow Transplantation
·
15
PDF
Extramedullary acute myeloid leukemia (eAML): Retrospective single center cohort study on clinico-pathological, molecular analysis and survival outcomes
2021
·
Khalid Halahleh
, Yazan Alhalaseh
, et al.
·
Annals of Medicine and Surgery
·
14
Influence of FLT3‐ITD and NPM1 status on allogeneic hematopoietic cell transplant outcomes in patients with cytogenetically normal AML
2019
·
Ivan Pasic
, Waleed Da'na
, et al.
·
European Journal Of Haematology
·
8
The Impact of Post-Hematopoietic Stem Cell Transplant Tyrosine Kinase Inhibitors in Philadelphia-Positive Acute Lymphoblastic Leukemia
2021
·
Khalid Halahleh
, Dalia Al Rimawi
, et al.
·
Hematology/Oncology and Stem Cell Therapy
·
3
PDF
Hematopoietic cell transplants in Jordan: different indications from the US and EU
2019
·
Khalid Halahleh
, Mahmoud M. Sarhan
, et al.
·
Bone Marrow Transplantation
·
3
PDF
Persistent microbiome dysbiosis following hematopoietic cell transplantation: Gut GvHD as the most severe manifestation of microbial disruption
2025
·
Hasan Hashem
, Muna Al Zughbieh
, et al.
·
Blood
·
1
PDF
Outcomes of Peripheral Blood Haploidentical Stem Cell Transplantation With Post-Transplant Cyclophosphamide and Earlier Initiation of Immunosuppression
2025
·
Mohammad Ma'koseh
, Zaid Abdel Rahman
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
1
PARADIGM-PV: a randomized, multicenter phase 4 study to assess the efficacy and safety of ropeginterferon alfa-2b in patients with low- or high-risk polycythemia vera
2025
·
Abdulraheem Yacoub
, Ghaith Abu-Zeinah
, et al.
·
Annals of Hematology
·
1
PDF
Eltrombopag Enhances Recovery from Cytopenias Due to Poor Graft Function after Hematopoietic Cell Transplantation
2025
·
Khalid Halahleh
, Maram Al-Ya'Goub
, et al.
·
BLOOD CELL THERAPY / The official journal of APBMT
·
1
PDF
Genetic Profiling and Risk Stratification of Acute Myeloid Leukemia (AML): Comparative Analysis of the Jordanian AML Cohort (JAMLC) to the German-Austrian AML Study Group (AMLSG)
2024
·
Zaid Abdel Rahman
, Abeer Yaseen
, et al.
·
Blood
·
1
PDF
Characteristics and Outcomes of Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma: A 14-Year Experience in a Limited Resource Setting
2024
·
Abeer Yaseen
, Mohammad Ma'koseh
, et al.
·
Blood
·
1
Paradigm-PV: A Global, Randomized, Multicenter, Two-Arm Phase IV Study to Assess the Efficacy and Safety of Ropeginterferon Alfa-2b in Low- and High-Risk Patients with Polycythemia Vera
2024
·
Abdulraheem Yacoub
, Ghaith Abu-Zeinah
, et al.
·
Blood
·
1
Clinical Characteristics and Outcomes of CML in Adolescents and Young Adults
2024
·
Kamal Al-rabi
, Mohammad Ma'koseh
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
1
Outcomes of Patients With Acute Promyelocytic Leukemia in Jordan: Real-World Data from a Tertiary Referral Center
2026
·
Mohammad Harb
, Leen Al-Kraimeen
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Point-of-Care Manufacturing of Anti–CD19.1-Chimeric Antigen Receptor-T Cells Using CliniMACS Prodigy: Real-World Experience From Jordan
2026
·
Khalid Halahleh
, Ahmad Abu-Khader
, et al.
·
JCO Global Oncology
Outcomes of allogeneic hematopoietic cell transplantation in patients with carbapenem-resistant organisms infection: a propensity score-matched analysis
2026
·
Abeer Yaseen
, Teeba Mubaydeen
, et al.
·
Frontiers in Transplantation
PDF
Real-world outcomes of multiple myeloma in a resource-constrained setting: a 14-year experience from a tertiary cancer center in Jordan
2025
·
Abeer Yaseen
, Mohammad Ma'koseh
, et al.
·
Blood Global Hematology
The Impact of Carbapenem-Resistant Enterobacteriaceae (CRE) Infection on Outcomes of Allogeneic Hematopoietic Stem Cell Transplant: A Propensity Score Analysis
2025
·
Zaid Abdel Rahman
, Abeer Yaseen
, et al.
·
Transplantation and Cellular Therapy
Evolution of Outcomes in Autologous Stem Cell Transplantation for Hodgkin's Lymphoma over 2 Decades at King Hussein Cancer Center
2025
·
Abeer Yaseen
, Anas Zayed
, et al.
·
Transplantation and Cellular Therapy
Haematopoietic Cell Transplants in Adults Acute Lymphoblastic Leukaemia in a Resource-poor Middle East Country
2025
·
Khalid Halahleh
, Isra Muradi
, et al.
·
Journal of Stem Cell Therapy and Transplantation
PDF
Therapy-related Myeloid Neoplasms After Autologous Stem Cell Transplantation for Lymphoma: A Single-Center Experience
2025
·
Abeer Yaseen
, Anas Zayed
, et al.
·
BLOOD CELL THERAPY / The official journal of APBMT
PDF
Patient Characteristics and Treatment Outcomes of TP53 Mutated Myeloid Neoplasms : A Single Cancer Center Experience from the MENA Region
2024
·
Kamal Al-Rabi
, Mohammad Ma'Koseh
, et al.
·
Blood
CT-705 Survival Trends after Autologous Hematopoietic Stem Cell Transplantation for Lymphoma: A Single Center Experience over Two Decades
2024
·
Abeer Yaseen
, Anas Zayed
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Survival Trends after Autologous Hematopoietic Stem Cell Transplantation for Lymphoma: A Single Center Experience over Two Decades
2024
·
Abeer Yaseen
, Anas Zayed
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Show more works
View as search
Works count:
41
Citation count:
80
H-index:
4
I10-index:
3
Year
Topic
Type
